Tempest Therapeutics, Inc.
TPST
$0.91
-$0.08-7.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 81.07% | -588.78% | -14.53% | 55.39% | 27.53% |
| Total Depreciation and Amortization | 0.00% | -7.69% | -1.52% | -1.49% | -1.47% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -90.75% | 2,252.70% | 154.84% | -75.71% | -17.02% |
| Change in Net Operating Assets | 226.04% | 16.43% | 86.75% | -80.86% | -290.98% |
| Cash from Operations | 63.42% | -112.59% | 47.28% | 19.59% | -4.92% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | -92.36% |
| Issuance of Common Stock | 3.36% | -26.77% | 17,715.38% | -99.76% | 267.50% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3.36% | -54.98% | 28,876.92% | -98.92% | 266.44% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 82.62% | -3,158.03% | 102.85% | 6.43% | 17.43% |